Concepedia

Publication | Open Access

Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention

DOIFull Paper Access

168

Citations

19

References

2016

Year

André Leite Gonçalves, Adriana Martini Ferreira, Reinaldo Teixeira Ribeiro, Eliova Zukerman, José Cipolla‐Neto, Mário Fernando Prieto Peres
Journal of Neurology Neurosurgery & Psychiatry

Abstract

Melatonin 3 mg is better than placebo for migraine prevention, more tolerable than amitriptyline and as effective as amitriptyline 25 mg.

References

YearCitations

Page 1